Financials
- Market Capitalization 10 B
- Employee 711
- Founded 2004
- CEO Christopher Richard Anzalone
- Website www.arrowheadpharma.com
- Headquarter Delaware, United States
- FIGI BBG000BRVKH0
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 878 | ABVX Abivax SA - American Depositary Shares | 136.07 USD | +0.86% | -1.18% | +37.44% | +1257.98% | 10.69 B USD | ||
| 909 | CYTK Cytokinetics, Incorporated - Common Stock | 82.36 USD | +0.52% | -0.22% | +12.82% | +41.76% | 10.25 B USD | ||
| 921 | KRYS Krystal Biotech, Inc. - Common Stock | 345.35 USD | +1.74% | -5.60% | +5.35% | +84.55% | 10.18 B USD | ||
| 926 | NUVL Nuvalent, Inc. - Class A Common Stock | 123.96 USD | 0.00% | +0.18% | +0.45% | +30.55% | 9.79 B USD |
Frequently asked questions about Arrowhead Pharmaceuticals, Inc. - Common Stock
What is the Arrowhead Pharmaceuticals, Inc. - Common Stock stock price today?
The current price of Arrowhead Pharmaceuticals, Inc. - Common Stock (ARWR) is 70.96. Over the past 24 hours, the stock has changed by -1.32%. Follow the ARWR chart for real-time price dynamics.
What is the stock ticker of Arrowhead Pharmaceuticals, Inc. - Common Stock?
Arrowhead Pharmaceuticals, Inc. - Common Stock trades under the ticker ARWR. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Arrowhead Pharmaceuticals, Inc. - Common Stock stock going up?
ARWR has changed by -15.87% over the last week, -8.51% over the last month, and +81.48% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Arrowhead Pharmaceuticals, Inc. - Common Stock net income for the last quarter?
Arrowhead Pharmaceuticals, Inc. - Common Stock reported net income of -132.73 M for the last quarter. The previous quarter showed 30.81 M, which means net income changed by -530.79%.
How many employees does Arrowhead Pharmaceuticals, Inc. - Common Stock have?
As of the latest available data, Arrowhead Pharmaceuticals, Inc. - Common Stock has 711 employees. Workforce size can provide additional context about the company's scale and operations.
What is Arrowhead Pharmaceuticals, Inc. - Common Stock EBITDA?
Arrowhead Pharmaceuticals, Inc. - Common Stock EBITDA is -135.36 M, and its EBITDA margin is -183.57%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Arrowhead Pharmaceuticals, Inc. - Common Stock stock?
You can buy Arrowhead Pharmaceuticals, Inc. - Common Stock (ARWR) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Arrowhead Pharmaceuticals, Inc. - Common Stock stock?
Investing in Arrowhead Pharmaceuticals, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ARWR chart and related analysis on metatrader.com as part of your research.